← All stocks

Tyra Biosciences, Inc.

TYRA Net buying
CIK 0001863127 #2234 in the set updated 17 Sep 2026
Bought (120 mo)
$76.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$31.98M
$18.29M on a plan · $5.14M straight out of an exercise
Sold at will
$8.54M
33 of 134 sales
Net
+$44.99M
+$68.43M against sales at will

By person

23 insiders · 150 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$55.16M (8)
+$55.16M
10,259,291
17.19%
$211.12M
Boxer Capital, LLC entity
See Remarks
$11.64M (2)
+$11.64M
6,534,298
10.95%
$134.47M
Bensen Daniel
Chief Discovery Officer
$9.54M (55) scheduled
−$9.54M
146,981
0.2463%
$3.02M
−71.7%
Harris Todd
President and CEO
$8.12M (43) scheduled
−$8.12M
1,437,631
2.41%
$29.58M
−13.5%
Cormorant Asset Management, LP entity
Former 10% Owner
$5.00M (1)
+$5.00M
1,069,932
1.79%
$22.02M
Kjellson Nina S
Director
$4.41M (26)
−$4.41M
443,885
0.7438%
$9.13M
MVA Investors, LLC entity
10% owner
$3.50M (2)
−$3.50M
22,527
0.0377%
$463.57K
−92.2%
MORE ROBERT J
Director
$2.50M (1)
$5.25M (2) scheduled
−$2.75M
3,823,425
6.41%
$78.68M
+3,286%
Alta Partners NextGen Fund II Management, LLC entity
10% owner
$2.50M (1)
+$2.50M
4,080,296
6.84%
$83.97M
+3,513%
KAPLAN GILLA
Director
$1.16M (6)
−$1.16M
28,231
0.0473%
$580.95K
−79.0%
Fuhrman Alan
Chief Financial Officer
$151.95K (1)
+$151.95K
36,164
0.0606%
$744.20K
Verjee Rehan
Director
$20.00K (1)
+$20.00K
972
0.0016%
$20.00K
Boxer Capital Management, LLC entity
See remarks
4,448,359
7.45%
$91.54M
−31.0%
Canaan XI L.P.
10% owner
473,396
0.7933%
$9.74M
Hudkins Robert L.
Chief Technology Officer
273,576
0.4584%
$5.63M
+1.3%
Swanson Ronald V.
Chief Scientific Officer
273,254
0.4579%
$5.62M
+1.2%
CHEN ISAN
Director
192,783
0.3230%
$3.97M
+46.8%
van den Boom Esther
Chief Financial Officer
143,151
0.2399%
$2.95M
+20.7%
Tada Hiroomi
Chief Medical Officer
86,435
0.1448%
$1.78M
+10.9%
Patel Piyush R.
Chief Development Officer
73,794
0.1237%
$1.52M
−45.4%
Rueb Yuliya
Vice President, Finance (PAO)
43,354
0.0726%
$892.16K
+23.8%
Warner Douglas J
Chief Medical Officer
25,000
0.0419%
$514.46K
Ashar Bhavesh
Chief Operating Officer
15,013
0.0252%
$308.94K
Insider
Date
Role
Action
Shares
Price
Amount
KAPLAN GILLA
18 Jun 2025
Director
Sell
9,568
$9.78
$93.60K
KAPLAN GILLA
17 Jun 2025
Director
Sell
10
$10.35
$103.50
KAPLAN GILLA
16 Jun 2025
Director
Sell
6,814
$10.38
$70.73K
KAPLAN GILLA
13 Jun 2025
Director
Sell
15,000
$10.31
$154.58K
KAPLAN GILLA
12 Jun 2025
Director
Sell
30,000
$10.31
$309.26K
Kjellson Nina S
5 Feb 2025
Director
Sell indirect
3,511
$13.76
$48.32K
Kjellson Nina S
5 Feb 2025
Director
Sell indirect
1,890
$13.76
$26.01K
Kjellson Nina S
23 Jan 2025
Director
Sell indirect
4,825
$16.26
$78.47K
Kjellson Nina S
21 Jan 2025
Director
Sell indirect
3,993
$16.36
$65.34K
Kjellson Nina S
17 Jan 2025
Director
Sell indirect
461
$16.40
$7.56K
Kjellson Nina S
17 Jan 2025
Director
Sell indirect
12,808
$16.40
$210.05K
Kjellson Nina S
16 Jan 2025
Director
Sell indirect
835
$16.29
$13.60K
Kjellson Nina S
16 Jan 2025
Director
Sell indirect
6,944
$16.29
$113.10K
Kjellson Nina S
25 Nov 2024
Director
Sell indirect
566
$16.84
$9.53K
Kjellson Nina S
25 Nov 2024
Director
Sell indirect
4,706
$16.84
$79.24K
Kjellson Nina S
7 Nov 2024
Director
Sell indirect
2,371
$17.32
$41.06K
Kjellson Nina S
7 Nov 2024
Director
Sell indirect
19,720
$17.32
$341.51K
Kjellson Nina S
6 Nov 2024
Director
Sell indirect
5,635
$17.18
$96.78K
Kjellson Nina S
6 Nov 2024
Director
Sell indirect
46,856
$17.18
$804.78K
Kjellson Nina S
5 Nov 2024
Director
Sell indirect
1,126
$16.77
$18.88K
Kjellson Nina S
5 Nov 2024
Director
Sell indirect
9,367
$16.77
$157.07K
Kjellson Nina S
4 Nov 2024
Director
Sell indirect
116
$17.01
$1.97K
Kjellson Nina S
4 Nov 2024
Director
Sell indirect
960
$17.01
$16.33K
Kjellson Nina S
1 Nov 2024
Director
Sell indirect
73
$17.16
$1.25K
Kjellson Nina S
1 Nov 2024
Director
Sell indirect
2,878
$16.54
$47.61K
Kjellson Nina S
1 Nov 2024
Director
Sell indirect
604
$17.16
$10.36K
Kjellson Nina S
1 Nov 2024
Director
Sell indirect
23,938
$16.54
$396.04K
Kjellson Nina S
31 Oct 2024
Director
Sell indirect
10,750
$16.46
$176.94K
Kjellson Nina S
31 Oct 2024
Director
Sell indirect
89,390
$16.46
$1.47M
Kjellson Nina S
30 Oct 2024
Director
Sell indirect
1,189
$16.17
$19.22K
Kjellson Nina S
30 Oct 2024
Director
Sell indirect
9,889
$16.17
$159.90K
MVA Investors, LLC
10 Feb 2023
10% owner
Sell
65,568
$13.40
$878.61K
MVA Investors, LLC
9 Feb 2023
10% owner
Sell
200,000
$13.10
$2.62M

What was left out

Form 4 filings counted 167
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 43
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 36,208,337
Sales filed before the plan box existed 2
History held since 17 Sep 2021